These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12874768)

  • 41. [Clinicopathologic characteristics of plasma cell myeloma with marrow fibrosis].
    Li HL; Ru K; Sun Q; Li ZQ; Zhang HJ; Ma Y; Xian M; Qiu LG; Liu EB
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):327-331. PubMed ID: 28468039
    [No Abstract]   [Full Text] [Related]  

  • 42. An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era.
    Tan D; Teoh G; Lau LC; Lim A; Lim TH; Yap KC; Premalatha P; Lao ZT; Wee N; Choo C; Wee HC; Su S; Lee YS; Lee LH; Hwang W; Goh YT
    Am J Hematol; 2010 Oct; 85(10):752-6. PubMed ID: 20721886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmablastic IgM multiple myeloma with hypocellular bone marrow.
    Arter ZL; Miles D; Mignano S; Cordaro D; Roswarski J
    Ann Hematol; 2020 Apr; 99(4):895-896. PubMed ID: 32055929
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasmablastic multiple myeloma is associated with increased vascular endothelial growth factor immunoexpression.
    Ribas C; Colleoni GW; Almeida MS; Aguiar KC; Silva MR; Bordin JO
    Braz J Med Biol Res; 2005 Nov; 38(11):1609-13. PubMed ID: 16258629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
    Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
    Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma.
    Flactif M; Zandecki M; Laï JL; Bernardi F; Obein V; Bauters F; Facon T
    Leukemia; 1995 Dec; 9(12):2109-14. PubMed ID: 8609724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgD plasmablastic myeloma: a case report with emphasis on the cytological features.
    Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(3):1250-4. PubMed ID: 24696745
    [No Abstract]   [Full Text] [Related]  

  • 49. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous occurrence of myelomonocytic leukemia and multiple myeloma: involvement of common leukemic progenitors and their developmental abnormality of "lineage infidelity".
    Akashi K; Harada M; Shibuya T; Fukagawa K; Kimura N; Sagawa K; Yoshikai Y; Teshima T; Kikuchi M; Niho Y
    J Cell Physiol; 1991 Sep; 148(3):446-56. PubMed ID: 1655817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.
    Paiva B; Almeida J; Pérez-Andrés M; Mateo G; López A; Rasillo A; Vídriales MB; López-Berges MC; Miguel JF; Orfao A
    Cytometry B Clin Cytom; 2010 Jul; 78(4):239-52. PubMed ID: 20155853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of new IgG lambda myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma.
    Hamilton MS; Ball J; Bromidge E; Lowe J; Franklin IM
    Br J Haematol; 1990 Jul; 75(3):378-84. PubMed ID: 2117464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486.
    Trendle MC; Leong T; Kyle RA; Katzmann JA; Oken MM; Kay NE; Van Ness BG; Greipp PR
    Am J Hematol; 1999 Aug; 61(4):232-7. PubMed ID: 10440908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and risk stratification in multiple myeloma.
    van de Donk NW; Sonneveld P
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):791-813. PubMed ID: 25212883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients.
    Yousef S; Marvin J; Steinbach M; Langemo A; Kovacsovics T; Binder M; Kröger N; Luetkens T; Atanackovic D
    Blood Cancer J; 2015 Mar; 5(3):e285. PubMed ID: 25747678
    [No Abstract]   [Full Text] [Related]  

  • 57. Old and new immunophenotypic markers in multiple myeloma for discrimination of responding and relapsing patients: The importance of "normal" residual plasma cell analysis.
    Pojero F; Casuccio A; Parrino MF; Cardinale G; Colonna Romano G; Caruso C; Gervasi F
    Cytometry B Clin Cytom; 2015; 88(3):165-82. PubMed ID: 25529228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
    Jelinek DF; Ahmann GJ; Greipp PR; Jalal SM; Westendorf JJ; Katzmann JA; Kyle RA; Lust JA
    Cancer Res; 1993 Nov; 53(21):5320-7. PubMed ID: 8221668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rare case of plasma cell myeloma with megakaryoblastic morphology mimicking acute leukemia.
    Liu K; Song H; Shi J; Zhang W; Mu R; Li L
    Indian J Pathol Microbiol; 2020; 63(3):485-487. PubMed ID: 32769348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements.
    Pan Z; Xie Q; Repertinger S; Richendollar BG; Chan WC; Huang Q
    Hum Pathol; 2013 Oct; 44(10):2139-48. PubMed ID: 23791008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.